Authors:
Lewis, J
Eiben, LJ
Nelson, DL
Cohen, JI
Nichols, KE
Ochs, HD
Notarangelo, LD
Duckett, CS
Citation: J. Lewis et al., Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family, CLIN IMMUNO, 100(1), 2001, pp. 15-23
Authors:
Richter, BWM
Mir, SS
Eiben, LJ
Lewis, J
Reffey, SB
Frattini, A
Tian, L
Frank, S
Youle, RJ
Nelson, DL
Notarangelo, LD
Vezzoni, P
Fearnhead, HO
Duckett, CS
Citation: Bwm. Richter et al., Molecular cloning of ILP-2, a novel member of the inhibitor of apoptosis protein family, MOL CELL B, 21(13), 2001, pp. 4292-4301
Authors:
Czar, MJ
Kersh, EN
Mijares, LA
Lanier, G
Lewis, J
Yap, G
Chen, A
Sher, A
Duckett, CS
Ahmed, R
Schwartzberg, PL
Citation: Mj. Czar et al., Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP, P NAS US, 98(13), 2001, pp. 7449-7454
Authors:
Kim, RH
Flanders, KC
Reffey, SB
Anderson, LA
Duckett, CS
Perkins, ND
Roberts, AB
Citation: Rh. Kim et al., SNIP1 inhibits NF-kappa B signaling by competing for its binding to the C/H1 domain of CBP/p300 transcriptional Co-activators, J BIOL CHEM, 276(49), 2001, pp. 46297-46304
Authors:
Reffey, SB
Wurthner, JU
Parks, WT
Roberts, AB
Duckett, CS
Citation: Sb. Reffey et al., X-linked inhibitor of apoptosis protein functions as a cofactor in transforming growth factor-beta signaling, J BIOL CHEM, 276(28), 2001, pp. 26542-26549
Authors:
Larisch, S
Yi, YS
Lotan, R
Kerner, H
Eimerl, S
Parks, WT
Gottfried, Y
Reffey, SB
de Caestecker, MP
Danielpour, D
Book-Melamed, N
Timberg, R
Duckett, CS
Lechleider, RJ
Steller, H
Orly, J
Kim, SJ
Roberts, AB
Citation: S. Larisch et al., A novel mitochondrial septin-like protein, ARTS, mediates apoptosis dependent on its P-loop motif, NAT CELL BI, 2(12), 2000, pp. 915-921
Authors:
Nakajima, H
Cella, M
Bouchon, A
Grierson, HL
Lewis, J
Duckett, CS
Cohen, JI
Colonna, M
Citation: H. Nakajima et al., Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity, EUR J IMMUN, 30(11), 2000, pp. 3309-3318
Citation: Ss. Mir et al., Differential effects of CD30 activation in anaplastic large cell lymphoma and Hodgkin disease cells, BLOOD, 96(13), 2000, pp. 4307-4312